Wolfgang Miesbach on Frailty in Hemophilia: New Data Shows 3x Higher Risk
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a proud post on Linkedin:
“Frailty in Haemophilia: A Hidden Challenge for Aging Patients.
New research reveals a concerning trend: People with haemophilia (PWH) face significantly higher rates of frailty compared to the general population—nearly 3x higher in those over 65.
Alarming frailty rates:
PWH aged 50-64: 17% have frailty vs. expected ~5%
PWH aged ≥65: 29% have frailty vs. 10% general population
This means PWH are aging like they’re 15+ years older
The ‘premature aging’ effect:
30% annual fall rate in PWH (~age 40)
Equivalent to general population >75 years
58% experience polypharmacy vs 45% in peers
The Geriatric Topics Affecting PWH:
- Falls and Immobility – chronic joint damage creates mechanical instability
- Cognitive Concerns – potential links to cerebral microbleeds under investigation
- Functional Incontinence – arthropathy limits timely toilet access
- Medication Overload – complex regimens for multiple conditions
Clinical Game-Changers:
- Clinical Frailty Scale screening to be recommended for all PWH >50
- Comprehensive Geriatric Assessment proven to reverse/slow frailty
- Novel care pathways needed: physiotherapy, occupational therapy, pharmacy optimization
This research highlights the urgent need for age-appropriate care pathways in haemophilia treatment centers. As our PWH population lives longer thanks to better treatments, we must address the unique challenges of aging with a bleeding disorder.”
Amazing review by Wolfgang Miesbach, read the full article here.
Title: Frailty and frailty syndromes in persons with haemophilia: a review
Authors: William McKeown, Stephanie Taylor, Susan Shapiro
Stay informed with Hemostasis Today.
-
Jan 6, 2026, 13:39JAMA Neurology: No Added Benefit of Dual Therapy After Ischemic Stroke in Case of AFib
-
Jan 6, 2026, 10:10This is Fantastic: Shirley D’Sa on Transfusion-Free Christmas Milestone for 𝛃-Thalassaemia Patient at UCLH
-
Jan 6, 2026, 09:53Hamideh Yadegari: Coagulation–Inflammation Crosstalk: Mechanisms, Pathways, and Clinical Implications
-
Jan 6, 2026, 09:52Antoine Francis: Plasma is Not Just Another Component of Healthcare…
-
Jan 6, 2026, 09:45Hurry to Join EHC Youth Leadership Workshop 2026
-
Jan 6, 2026, 09:41Andrew Petrosoniak Makes It to N1 on EMCases Best of 2025!
-
Jan 6, 2026, 09:35Sara Ng: Moving Beyond Management to Stewardship – “Advancing Anticoagulation Stewardship” Released by NQF
-
Jan 6, 2026, 09:30Wolfgang Miesbach: Excellent 4-Year Data of Etranacogene Dezaparvovec in Haemophilia B
-
Jan 6, 2026, 09:09Abdulrahman Nasiri: A New Perspective on Avatrombopag in Aplastic Anemia